On the other hand, activation of STING supports tumor development by facilitating the infiltration of Tregs into the tumor microenvironment, upregulation of immune checkpoint molecules, and secretion of IL-10, which collectively serve to suppress T cell activity [166–168]. The gene discussed is STING1; the disease is neoplasm.